This Month in Adult Urology

May 2018 in “ The Journal of urology/The journal of urology ”

Joseph A. Smith

TLDR The document highlights recent findings and treatments in urology, including prostate cancer diagnostics, urinary incontinence, and new therapies.

The document "This Month in Adult Urology" from August 2018 covered various studies and findings in the field of urology. Key topics included the diagnostic accuracy of multiparametric MRI and targeted biopsy for prostate cancer, the prevalence of urinary incontinence in men, and the outcomes of different therapies for prostate cancer. It also discussed the effectiveness of a new tissue-engineered oral mucosa graft for anterior urethroplasty, the impact of androgen deprivation therapy on cognitive function, and the results of water vapor thermal therapy for benign prostatic hyperplasia. Additionally, the document highlighted the limitations of targeted antimicrobial prophylaxis in preventing sepsis post-prostate biopsy and the outcomes of cystic renal cell carcinoma treatments.

View this study on auajournals.org →

Discuss this study in the Community →

Similar Research

6 / 1000+ results

research Side Effects of Androgen Deprivation Therapy: Monitoring and Minimizing Toxicity

228 citations, February 2003 in “Urology”

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.

research Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects

35 citations, January 2012 in “The Journal of Sexual Medicine”

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

research Androgen Deprivation Therapy May Be a More Effective COVID-19 Prophylactic Than Therapeutic Strategy

12 citations, August 2020 in “Annals of Oncology”

Androgen deprivation therapy might be better for preventing COVID-19 than treating it.

research Impact of Androgen Deprivation Therapy on Mortality of Prostate Cancer Patients with COVID-19: A Propensity Score-Based Analysis

9 citations, November 2021 in “Infectious Agents and Cancer”

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Prolongation of Off-Cycle Interval by Finasteride Is Not Associated with Survival Improvement in Intermittent Androgen Deprivation Therapy in LNCaP Tumor Model

research Prolongation of Off-Cycle Interval by Finasteride Is Not Associated with Survival Improvement in Intermittent Androgen Deprivation Therapy in LNCaP Tumor Model

9 citations, September 2009 in “The Prostate”

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

research Recent Discoveries and Developments of Androgen Receptor-Based Therapy for Prostate Cancer

17 citations, January 2015 in “MedChemComm”

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

This Month in Adult Urology

Related Community Posts Join

community Protac degradation of the androgen receptor in mice shows good efficacy and no systemic drug could be found

community For those on TRT and suffer from a more aggressive type of (AGA) hairloss, what are your hair safe protocols?

community Can finasteride affect on your muscle and other things?

community Is there a consensus on RU these days? Pyril turned out to be a bust right?

community Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China

community Extreme regimen and still miniaturized hairs. AGA is just impossible to beat.